Chemoinformaics analysis of (E)-11-Tetradecen-1-ol acetate
| Molecular Weight | 254.414 | nRot | 12 |
| Heavy Atom Molecular Weight | 224.174 | nRig | 2 |
| Exact Molecular Weight | 254.225 | nRing | 0 |
| Solubility: LogS | -5.762 | nHRing | 0 |
| Solubility: LogP | 6.208 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 48.3278 |
| nHD | 0 | BPOL | 32.7002 |
| QED | 0.277 |
| Synth | 2.136 |
| Natural Product Likeliness | 1.185 |
| NR-PPAR-gamma | 0.027 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.011 |
| HIA | 0.003 |
| CACO-2 | -4.609 |
| MDCK | 0.0000216 |
| BBB | 0.332 |
| PPB | 0.972342 |
| VDSS | 1.627 |
| FU | 0.0290753 |
| CYP1A2-inh | 0.939 |
| CYP1A2-sub | 0.181 |
| CYP2c19-inh | 0.621 |
| CYP2c19-sub | 0.068 |
| CYP2c9-inh | 0.406 |
| CYP2c9-sub | 0.873 |
| CYP2d6-inh | 0.111 |
| CYP2d6-sub | 0.096 |
| CYP3a4-inh | 0.409 |
| CYP3a4-sub | 0.093 |
| CL | 3.315 |
| T12 | 0.269 |
| hERG | 0.125 |
| Ames | 0.005 |
| ROA | 0.012 |
| SkinSen | 0.96 |
| Carcinogencity | 0.13 |
| EI | 0.983 |
| Respiratory | 0.315 |
| NR-Aromatase | 0.131 |
| Antiviral | Yes |
| Prediction | 0.746337 |